TB-500 half-life is estimated at 2–3 hours in plasma, though some sources say 2–3 days. Learn how long TB-500 stays in your system and what affects it.
TB-500 has an estimated plasma half-life of about 2 to 3 hours based on limited animal and preclinical data, though some vendor and community sources claim a longer window of 2 to 3 days. That means the peptide is usually cleared from the bloodstream relatively quickly, but its downstream effects on tissue repair may last longer than the drug itself. Human pharmacokinetic studies are scarce, so any specific number should be treated as an estimate, not a guarantee.
What Is TB-500?
TB-500 is a synthetic version of a short fragment of thymosin beta-4, a protein naturally found in most human cells. The fragment is often called Tβ4 or TB4 fragment. In research settings, TB-500 is studied for its potential role in cell migration, actin binding, and tissue repair. It is not FDA-approved for human use in the United States.
Because TB-500 is not an approved drug, dosing information comes mostly from animal studies, anecdotal reports, and vendor recommendations. That makes pharmacokinetic data like half-life less reliable than for prescription medications.
Reported TB-500 Half-Life Values
| Source type | Reported half-life | Notes |
|---|---|---|
| Preclinical/animal data | ~2–3 hours | Native thymosin beta-4 is cleared quickly from plasma. |
| Vendor/community claims | ~2–3 days | May reflect the acetylated fragment’s stability or tissue binding. |
| Human data | Not well established | No large published human PK studies for TB-500. |
This table shows the wide range you will see online. The truth likely depends on the form of TB-500, the route of administration, and how you measure “half-life” — plasma clearance versus biological effect.
How Long Does TB-500 Stay in Your System and Why It Matters?
If the plasma half-life is around 2 to 3 hours, then most of the peptide would be cleared from blood within roughly 4 to 5 half-lives, or about 10 to 15 hours. A 2–3 day half-life would extend that to 1 to 2 weeks for near-complete plasma clearance. But biological effects on tissue repair can outlast the peptide itself because TB-500 may trigger downstream signaling that persists after the molecule is gone.
Detection times in drug tests are different from half-life. TB-500 is not part of standard drug panels, and anti-doping labs use specialized tests for thymosin beta-4 fragments. How long TB-500 stays detectable depends on the test, the dose, and the individual.
Half-life also helps estimate how often a drug needs to be administered to maintain steady levels. A short half-life usually means more frequent dosing; a longer half-life allows less frequent dosing. But for TB-500, the optimal dose and schedule are unknown because there are no approved human trials.
Many online protocols suggest twice-weekly injections, which would align with a longer half-life. If the half-life is truly only a few hours, that schedule would produce large peaks and troughs. Without human data, both approaches remain speculative.
What Affects TB-500 Half-Life?
- Route of administration: Subcutaneous or intramuscular injections may absorb at different rates than other routes.
- Dose: Higher doses can temporarily saturate clearance pathways, though this is not well studied for TB-500.
- Individual metabolism: Age, liver and kidney function, and body composition can change peptide clearance.
- Formulation: Acetylation, lyophilization, and storage conditions may affect stability before injection.
- Measurement method: Plasma half-life, tissue half-life, and effect duration are not the same thing.
Half-Life Compared With Other Peptides
TB-500 is often discussed alongside other research peptides, each with its own pharmacokinetic profile. For example, aod 9604 half-life is commonly cited as shorter, while cjc 1295 no dac half-life is also brief. If you are comparing compounds, look at the specific study or label rather than assuming all peptides behave the same.
Research blends are also common. A product like bpc-157 + tb-500 + ghk-cu + kpv; klow blend combines multiple peptides, and each component has its own half-life. Similarly, ghk-cu + tb-500 + bpc-157; glow blend is a mix where TB-500’s clearance may not match the other ingredients.
If you are looking for where to buy bpc-157 and tb-500, remember that quality and purity vary widely, and these products are not approved for human consumption.
Safety, Legality, and Medical Advice
TB-500 is not FDA-approved for human use in the United States. It is sold as a research chemical, and products may be mislabeled, contaminated, or impure. Injecting unapproved peptides carries risks of infection, allergic reaction, and unknown long-term effects.
If you are considering TB-500 for any health condition, talk to a licensed healthcare professional. They can discuss approved alternatives and help you understand the risks. No peptide should replace proven medical care.
Frequently Asked Questions
How long does TB-500 stay in your system?
Most estimates suggest TB-500 is cleared from plasma within 10–15 hours if the half-life is 2–3 hours, or up to 1–2 weeks if it is 2–3 days. However, these are estimates based on limited data, and detection times vary by test.
Is TB-500 half-life 2 hours or 3 days?
Both numbers appear online, but they describe different things. The 2–3 hour figure comes from preclinical plasma clearance of native thymosin beta-4, while the 2–3 day figure may reflect the synthetic fragment’s stability or tissue binding. There is no large human study to confirm either value.
Can I take TB-500 less often because of its half-life?
Some protocols suggest twice-weekly dosing based on a longer assumed half-life, but there is no approved human dosing schedule for TB-500. Frequency should not be guessed; consult a healthcare professional and rely on approved treatments where possible.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.